Metastatic Melanoma

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)
Paolo Antonio Ascierto, E Simeone, V Chiarion Sileni, P Queirolo, M Del Vecchio, L Di Guardo, M Guidoboni, P Marchetti, GC Antonini Cappellini, PF Ferrucci, F Cognetti, MG Bernengo, M Guida, R Marconcini, M Mandalà, C Cimminiello, G Rinaldi, M Aglietta, L Calabrò, M Maio

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P69; DOI: 10.1186/2051-1426-1-S1-P69
Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
Courtney Regan, Michael Nishimura, Ann Lau Clark, Kelly Moxley, Gina Scurti, Vladimir Slepushkin, Andre Roy, Kathy Schonely, Boro Dropulic, Joseph Clark

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P31; DOI: 10.1186/2051-1426-1-S1-P31
Adoptively transferred melanoma-reactive CTL primed in the presence of IL-21 and transferred with concurrent CTLA4 blockade results in enhanced CTL persistence and tumor regression
Cassian Yee, Aude Chapuis, Phil Greenberg, Ivy Lai, John A Thompson, Kim Margolin

Journal for ImmunoTherapy of Cancer Feb 2014, 2 (Suppl 1) O2; DOI: 10.1186/2051-1426-2-S1-O2
Minor tumor infiltrating B cells opened a door to reveal and eliminate cancer initiating cells in metastatic melanomas
Beatrix Kotlan, Gabriella Liszkay, Gyorgy Naszados, Judit Olasz, Szabolcs Horvath, Vanda Plotar, Andras Szollar, Istvan Nagy Vamosi, Akos Savolt, Laszlo Toth, Orsolya Csuka, Maria Godeny, Miklos Kasler, Francesco M Marincola

Journal for ImmunoTherapy of Cancer Feb 2014, 2 (Suppl 1) P4; DOI: 10.1186/2051-1426-2-S1-P4

Main menu

Metastatic Melanoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Metastatic Melanoma

Pages